Live Investor Briefing
Live Investor Briefing
Sydney, Aug 16, 2019 AEST (ABN Newswire) - Anatara Lifesciences Ltd's (ASX:ANR) CEO, Steve Lydeamore will be presenting to investors at a Monsoon Communications Twilight Investor Briefing event in Melbourne next week. Investors interested in attending this presentation are invited to reach out.

Monsoon Communications Twilight Investor Briefing

Steve will provide an update on Anatara's work in gastrointestinal health for both humans and animals, alongside AdAlta Ltd:

* Thursday 22nd August 2019
* 4.15pm for 4.30pm
* FB Rice Boardroom, Level 14, 90 Collins Street, Melbourne

About Anatara Lifesciences Ltd

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit



Investor and Media inquiries

Steven Lydeamore
Chief Executive Officer
Anatara Lifesciences Ltd
T: +61-438-027-172

Sue MacLeman
Anatara Lifesciences Ltd
T: +61-437-211-200

Related Companies

Anatara Lifesciences Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 10) (Last 30 Days: 69) (Since Published: 1959)